393 related articles for article (PubMed ID: 26112660)
1. Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.
Mahévas M; Michel M; Vingert B; Moroch J; Boutboul D; Audia S; Cagnard N; Ripa J; Menard C; Tarte K; Mégret J; Le Gallou S; Patin P; Thai L; Galicier L; Bonnotte B; Godeau B; Noizat-Pirenne F; Weill JC; Reynaud CA
J Autoimmun; 2015 Aug; 62():22-30. PubMed ID: 26112660
[TBL] [Abstract][Full Text] [Related]
2. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
Mahévas M; Patin P; Huetz F; Descatoire M; Cagnard N; Bole-Feysot C; Le Gallou S; Khellaf M; Fain O; Boutboul D; Galicier L; Ebbo M; Lambotte O; Hamidou M; Bierling P; Godeau B; Michel M; Weill JC; Reynaud CA
J Clin Invest; 2013 Jan; 123(1):432-42. PubMed ID: 23241960
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
Piatek CI; Bocian H; Algaze S; Weitz IC; O'Connell C; Liebman HA
Acta Haematol; 2020; 143(3):244-249. PubMed ID: 31665725
[TBL] [Abstract][Full Text] [Related]
4. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.
Bussone G; Ribeiro E; Dechartres A; Viallard JF; Bonnotte B; Fain O; Godeau B; Michel M
Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460
[TBL] [Abstract][Full Text] [Related]
6. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
[TBL] [Abstract][Full Text] [Related]
7. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment.
Michel M
Presse Med; 2014 Apr; 43(4 Pt 2):e97-e104. PubMed ID: 24680421
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients.
Roumier M; Loustau V; Guillaud C; Languille L; Mahevas M; Khellaf M; Limal N; Noizat-Pirenne F; Godeau B; Michel M
Am J Hematol; 2014 Sep; 89(9):E150-5. PubMed ID: 24847759
[TBL] [Abstract][Full Text] [Related]
9. Warm autoimmune hemolytic anemia is an IgM-IgG immune complex disease.
Stahl D; Sibrowski W
J Autoimmun; 2005 Dec; 25(4):272-82. PubMed ID: 16242913
[TBL] [Abstract][Full Text] [Related]
10. Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia.
Stahl D; Lacroix-Desmazes S; Heudes D; Mouthon L; Kaveri SV; Kazatchkine MD
Blood; 2000 Jan; 95(1):328-35. PubMed ID: 10607720
[TBL] [Abstract][Full Text] [Related]
11. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center.
William J; Euler C; Shlomchik MJ
J Immunol; 2005 Jun; 174(11):6879-87. PubMed ID: 15905530
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hemolytic anemia.
Čermák J; Písačka M
Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
[TBL] [Abstract][Full Text] [Related]
13. A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).
Michel M; Terriou L; Roudot-Thoraval F; Hamidou M; Ebbo M; Le Guenno G; Galicier L; Audia S; Royer B; Morin AS; Marie Michot J; Jaccard A; Frenzel L; Khellaf M; Godeau B
Am J Hematol; 2017 Jan; 92(1):23-27. PubMed ID: 27696475
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy treatments of warm autoimmune hemolytic anemia.
Liu B; Gu W
Clin Dev Immunol; 2013; 2013():561852. PubMed ID: 24106518
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A
PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021
[TBL] [Abstract][Full Text] [Related]
17. Primary IgA-mediated Autoimmune Hemolytic Anemia in an Infant Successfully Treated With Rituximab.
van den Akker M; Smolders D; Mahieu S; Bonouvrie K; van der Werf Ten Bosch J
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e615-e619. PubMed ID: 32118812
[TBL] [Abstract][Full Text] [Related]
18. Warm autoimmune hemolytic anemia.
Naik R
Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study.
Lecouffe-Desprets M; Néel A; Graveleau J; Leux C; Perrin F; Visomblain B; Artifoni M; Masseau A; Connault J; Pottier P; Agard C; Hamidou M
Autoimmun Rev; 2015 Nov; 14(11):1023-8. PubMed ID: 26162301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
